Changes in Glaucoma Medication during the Past Eight Years and Future Directions in Japan Based on an Insurance Medical Claim Database

<div>Change in antiglaucoma ophthalmic solutions in three years among newly medicated patients. (a) Change in bottles of antiglaucoma ophthalmic solution. (b) Change in the number of antiglaucoma ophthalmic agents. PG: prostaglandin analogue; BB: beta blocker; CAI: carbonic anhydrase inhibitor.</div>

Journal of Ophthalmology

fig4

Figure 4

Figure 4: Changes in Glaucoma Medication during the Past Eight Years and Future Directions in Japan Based on an Insurance Medical Claim Database 